P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients - Wikidata - wikimedia - TriplyDB

P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients

P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients

http://www.wikidata.org/entity/Q28386398

about

Extracellular purines, purinergic receptors and tumor growth.Targeting calcium signaling in cancer therapy.Purinergic Signalling: Therapeutic Developments.Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.

P2860

Q38870205-32EC2802-778A-4774-81A8-5734806FDC55 Q39101957-08EDB90A-8B63-481B-A644-226856C7D2F0 Q42367885-D1B8793B-A30C-4BAD-BBF6-20ED8EA646BB Q46026307-CE826B07-9003-4CD4-820E-843ABB3FFCC6

P2860

P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients

http://www.wikidata.org/entity/Q28386398

description

2015 nî lūn-bûn

@nan

2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

P2X3 purinergic receptor overe ...... atocellular carcinoma patients

@ast

P2X3 purinergic receptor overe ...... atocellular carcinoma patients

@en

P2X3 purinergic receptor overe ...... atocellular carcinoma patients

@nl

type

label

P2X3 purinergic receptor overe ...... atocellular carcinoma patients

@ast

P2X3 purinergic receptor overe ...... atocellular carcinoma patients

@en

P2X3 purinergic receptor overe ...... atocellular carcinoma patients

@nl

prefLabel

P2X3 purinergic receptor overe ...... atocellular carcinoma patients

@ast

P2X3 purinergic receptor overe ...... atocellular carcinoma patients

@en

P2X3 purinergic receptor overe ...... atocellular carcinoma patients

@nl

P1433

Q28386398-F79C3A6B-3401-449C-8074-EB3DB82CC07D

P1476

Q28386398-AE8E1026-64DA-4BC9-A8BD-59402B530890

P2093

Q28386398-5183AF2A-A901-443C-ACA6-320C7B64E30C

Q28386398-6F168740-8C6D-490F-B7C3-5D9DD2E1B902

Q28386398-929FC3AC-A759-46F4-BDB1-C179E71327DC

Q28386398-E718219E-DC14-4EE0-A609-AE401344F33E

Q28386398-EF9DB868-4225-4DA3-8A9B-E6F9089D1F73

Q28386398-F2D43773-09ED-4876-87BE-29C769D14A33

Q28386398-F8599728-80C9-4A1B-8D78-228044877DC2

Q28386398-FE5C8445-2D5B-4D16-A1C0-DCDCCAE0D840

P2860

Q28386398-05B707C0-1050-4515-87F8-03F2E3D2D822

Q28386398-0822B5AE-C4F9-4C56-8D07-760E325FA7A7

Q28386398-1700ED9C-BD55-411F-8827-A7B6965F9A0F

Q28386398-1955D709-B121-4749-B0DB-3DEEF4C41839

Q28386398-1BA01CC2-F586-4ED7-9264-1655AB1EA7A0

Q28386398-20F1008E-C99A-4873-A6D9-6CD89D274B6C

Q28386398-23E377B6-5566-4113-9631-1A66552FD600

Q28386398-2A2B6A12-CC34-4157-8BFD-4B2F57A704DC

Q28386398-3610DC2C-6A89-4C69-979B-478A4D20A459

Q28386398-362E12E4-ABA2-4DBA-801E-C61466BBDFF1

P304

Q28386398-60286D68-DAA2-4316-80F8-70A1DB2287E4

P31

Q28386398-3C7F6E50-1FC3-4F83-9A6A-6EE3EB67C897

P3181

Q28386398-AE7FA76C-7FD9-42AC-8853-1F34FFAB9BF4

P356

Q28386398-8229A7C9-44D9-46C8-918A-CF3F5566FA89

P407

Q28386398-4C2E31C5-4665-4151-8899-3A7794E25838

P433

Q28386398-7D6C9A85-87C7-4409-971B-F05C44F6B8DC

P478

Q28386398-BD7F4402-8686-4F61-8F94-08712B1E0A82

P577

Q28386398-F14F8D1F-B534-4DC1-A878-0146A4C9DA35

P5875

Q28386398-6EBEFDAC-9CD0-4E88-A578-5D833DEB888F

P698

Q28386398-2DA33F86-8879-44EC-B209-EDDBA032AC89

P921

Q28386398-C545353A-0AFE-44E5-BAB1-1A1BD032B012

P932

Q28386398-AAD7A447-5454-4381-8E65-ED73F6561EEA

P3181

P356

ONCOTARGET.6240

P1433

P1476

P2X3 purinergic receptor overe ...... atocellular carcinoma patients

@en

P2093

Bo Hwa Sohn

http://www.w3.org/2001/XMLSchema#string

Dolores Lopez-Terrada

http://www.w3.org/2001/XMLSchema#string

Janielle P Maynard

http://www.w3.org/2001/XMLSchema#string

John A Goss

http://www.w3.org/2001/XMLSchema#string

Ju-Seog Lee

http://www.w3.org/2001/XMLSchema#string

Milton J Finegold

http://www.w3.org/2001/XMLSchema#string

Sundararajah Thevananther

http://www.w3.org/2001/XMLSchema#string

Xiaoying Yu

http://www.w3.org/2001/XMLSchema#string

P2860

JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma

Molecular characterization and pharmacological properties of the human P2X3 purinoceptor

Purinergic signalling and cancer

The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism

Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase

P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP

Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles

Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma.

P304

41162-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4762190

http://www.w3.org/2001/XMLSchema#string

P356

10.18632/ONCOTARGET.6240

http://www.w3.org/2001/XMLSchema#string

P407

P433

38

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283448289

http://www.w3.org/2001/XMLSchema#string

P698

26517690

http://www.w3.org/2001/XMLSchema#string

P921

P932

4747397

http://www.w3.org/2001/XMLSchema#string